Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

William Taylor

Psychiatry Simpsonville, SC Medical Doctor

NPI 1184717001 CMS profile 99770

20 Powderhorn Rd, Simpsonville, SC 29681

Open in the dashboard

General payments

$1,809

114 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, William Taylor of Simpsonville, SC is reported in the CMS Open Payments database as having received $1,809 across 114 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $15 1
2023 General $55 4
2022 General $206 13
2021 General $756 45
2020 General $314 19
2019 General $462 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Taylor
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to William Taylor were reported at $0. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year William Taylor Psychiatry median Middle half National median
2019 $462 $184 $59–$605 $163
2020 $314 $119 $36–$372 $114
2021 $756 $143 $43–$576 $132
2022 $206 $153 $50–$590 $149
2023 $55 $170 $56–$651 $160
2024 $15 $179 $57–$673 $164
2025 $0 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Sunovion Pharmaceuticals Inc. $340 23 payments
  2. Neurocrine Biosciences, Inc. $272 17 payments
  3. AbbVie, Inc. $238 17 payments
  4. Janssen Pharmaceuticals, Inc $228 15 payments
  5. Vanda Pharmaceuticals Inc. $227 11 payments
  6. Otsuka America Pharmaceutical, Inc. $211 13 payments
  7. Alkermes, Inc. $133 7 payments
  8. Lundbeck LLC $99 7 payments
  9. ITI, Inc. $31 2 payments
  10. ACADIA Pharmaceuticals Inc $15 1 payment
  11. Other $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $1,809 114 payments
Products named General payments · program years 2019–2024
  1. LATUDA $340 23 payments
  2. VRAYLAR $238 17 payments
  3. INVEGA SUSTENNA $228 15 payments
  4. HETLIOZ $227 11 payments
  5. FANAPT $227 11 payments
  6. INVEGA TRINZA $210 14 payments
  7. INGREZZA $194 12 payments
  8. ARISTADA INITIO $133 7 payments
  9. ARISTADA Cns $133 7 payments
  10. ARISTADA Cns $133 7 payments
  11. Other $803 49 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 42 drugs

Part D claims

2,168

Median for Psychiatry: 574

Drug cost

$181,301

Median for Psychiatry: $27,624

Branded share of claims

9.7%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Invega Sustenna Paliperidone Palmitate Brand 23 $84,682
Abilify Maintena Aripiprazole Brand 14 $40,795
Lurasidone Hcl Generic 64 $14,829
Trintellix Vortioxetine Hydrobromide Brand 16 $7,841
Paliperidone Er Paliperidone Brand 19 $4,722
Quetiapine Fumarate Generic 174 $3,756
Mirtazapine Generic 239 $2,288
Haloperidol Decanoate Generic 22 $1,850
Ziprasidone Hcl Generic 35 $1,655
Clozapine Generic 31 $1,611

The 10 drugs with the highest cost, of 42 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 9 billing codes

Paid by Medicare

$6,524

Medicare's payments for the services billed

Medicare patients

48

Average age 58

Services billed

115

23 women, 25 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 54%
Depression 44%
Arthritis 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VRAYLAR
  • AbbVie, Inc. $15
$15 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

114 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record